Maximum Dose of Nifedipine: 90 mg vs 120 mg
The maximum recommended dose of nifedipine is 90 mg daily for extended-release formulations, though immediate-release formulations have been studied up to 120 mg daily in divided doses. However, the FDA-approved labeling and most contemporary guidelines support 90 mg as the standard maximum dose for extended-release nifedipine.
FDA-Approved Dosing
The FDA drug label clearly states that nifedipine extended-release tablets are studied and approved in a dose range of 30 mg to 90 mg daily 1. The pharmacokinetic data shows that when administered as three 30 mg tablets (totaling 90 mg), the peak plasma concentration is 29% higher than predicted from lower doses, and three 30 mg tablets should not be considered interchangeable with a single 90 mg tablet due to substantially higher Cmax values 1.
Guideline Recommendations
Multiple ACC/AHA guidelines consistently list nifedipine dosing parameters:
- For immediate-release nifedipine: 30 to 90 mg daily orally 2, 3, 2, 4
- For slow/extended-release nifedipine: 30 to 180 mg orally 2, 3, 2, 4
However, this apparent discrepancy requires clarification. The 180 mg dose mentioned in older guidelines 2, 3, 2, 4 refers to slow-release formulations that may have different pharmacokinetic profiles than modern extended-release tablets. The 2018 and 2025 hypertension guidelines specify nifedipine LA (long-acting) 30-90 mg once daily as the recommended dosing range 5, 6.
Clinical Context and Formulation Differences
The confusion stems from different nifedipine formulations:
- Immediate-release capsules: Dosed up to 90 mg daily in divided doses (typically three times daily) 2, 3, 2, 4
- Extended-release tablets: Maximum 90 mg once daily 5, 6, 1
- Older slow-release preparations: Historical references to 120-180 mg may reflect older formulations no longer commonly used
Research studies have evaluated nifedipine at doses up to 120 mg daily in divided doses for angina and hypertension 7, 8, 9, 10, but these primarily used immediate-release formulations or older sustained-release preparations.
Special Populations
In pregnancy, immediate-release nifedipine has been studied up to 120 mg daily for severe preeclampsia 9, 11, 12, with the maximum daily dose listed as 180 mg in some guidelines 6, 13. However, for routine hypertension management in pregnancy, extended-release nifedipine 30-90 mg daily is preferred 6.
Safety Considerations
Important caveats:
- Immediate-release nifedipine carries a black box warning and should not be used for acute hypertension without concomitant beta-blocker therapy 2, 3, 2, 4, 14
- Higher doses increase the risk of peripheral edema (29% at 90 mg daily vs 10% with placebo) 1
- Dose-related hypotension, dizziness, flushing, and reflex tachycardia are more common at higher doses 2, 3, 2, 4
Practical Recommendation
For modern extended-release nifedipine formulations used in routine clinical practice, 90 mg daily is the maximum recommended dose 5, 6, 1. While historical literature references 120 mg daily, this typically refers to immediate-release formulations given in divided doses, which are no longer recommended for routine hypertension management due to safety concerns. If blood pressure remains uncontrolled at 90 mg daily of extended-release nifedipine, add a second antihypertensive agent from a different class rather than exceeding this dose.